KBLB stock performance?

Kraig Biocraft Laboratories, Inc. (KBLB) news stock charts

Kraig Biocraft Laboratories, Inc. (KBLB/KBLB.OB) Investment Summary:

Kraig Biocraft Laboratories, Inc. focuses on the development of protein based fiber using recombinant DNA technology for commercial applications in the textile and specialty fiber industries. Its products are used in military and police departments; industrial applications, including critical cables and abrasion/impact resistant components; and consumer applications. These fibers are also employed in safety equipment, and high strength composite materials for the aero-space industry. The company was founded in 2006 and is based in Lansing, Michigan.
www.kraiglabs.com
1 Employees
Founded in 2006

KRAIG BIOCRAFT LABORATORIES (KBLB:OTC BB)

LAST $0.03 USD
CHANGE TODAY +0.005 18.52%
VOLUME 1.7M
As of 8:10 PM 09/3/10 All times are local (Market data is delayed by at least 15 minutes).

Snapshot of KRAIG BIOCRAFT LABORATORIES (KBLB)

OPEN
$0.03
PREVIOUS CLOSE
$0.03
DAY HIGH
$0.03
DAY LOW
$0.02
52 WEEK HIGH
09/2/10 - $0.04
52 WEEK LOW
11/23/09 - $0.0090
MARKET CAP
16.8M
AVERAGE VOLUME 10 D
1.3M
EPS TTM
--
SHARES OUTSTANDING
523.6M
KBLB Does Not Pay Dividends
P/E TTM
--
K = Thousands  M = Millions  B = Billions

Key developments for KRAIG BIOCRAFT LABORATORIES (KBLB)

Kraig Biocraft Laboratories, Inc. expected to report Q2 2010 results on September 7, 2010. This event was calculated by Capital IQ (Created on September 1, 2010).

Kraig Biocraft Laboratories, Inc. expected to report Q2 2010 results on September 7, 2010. This event was calculated by Capital IQ (Created on September 1, 2010).

Kraig Biocraft Laboratories, Inc. Announces Auditors Changes

Kraig Biocraft Laboratories, Inc. terminated the engagement of Webb & Co. as the company's independent registered public accounting firm. The termination was approved by the company's board of directors. The company engaged, board of directors of the company appointed PS Stephenson & Co., P.C. as the company's independent registered public accounting firm. The company's financial statements for the fiscal years ended December 31, 2009 and 2008 were audited by Webb & Co.

Kraig Biocraft Laboratories, Inc. announced delayed 10-Q filing

On 08/16/2010, Kraig Biocraft Laboratories, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.

Kraig Biocraft Laboratories, Inc. financial resources

otc, otcbb, pinksheet, KBLB, ob Kraig Biocraft Laboratories, Inc.

KBLB Competitors

Company Last Change
No competitor information is available for KBLB.
Market data is delayed at least 15 minutes.
 

Industry Analysis

Valuation KBLB Industry Range
No financial data is available for KBLB.

KBLB transactions

Type
Date
Target
No transactions in the last 6 months.

More Recent Financial News About Kraig Biocraft Laboratories, Inc.

KRAIG BIOCRAFT LABORATORIES, INC Files SEC form 8-K/A, Changes in Registrant's Certifying Accountant, Financial State

Quote: Item 4.01 Changes in Registrant's Certifying Accountant. On August 12, 2010, the Board of Directors of Kraig Biocraft Laboratories, INC. (the "Company") approved the dismissal of Webb & Company ("Webb & Co.") as the Company's independent registered public accounting firm. Webb & Co. was, on the same day, dismissed from the service as the Company's independent registered public accounting firm. Concurrent with this action, on August 12, 2010, the Company engaged P...
Read article

Kraig Biocraft Laboratories, Inc. Announces Press Conference Advisory Regarding Laboratory Developments

Keywords: Kraig Biocraft Laboratories, Inc. Announces Press Conference Advisory Regarding Laboratory Developments, kblb.ob
Quote:
Read article

KRAIG BIOCRAFT LABORATORIES, INC Files SEC form 8-K, Changes in Registrant's Certifying Accountant, Financial Stateme

Quote: Item 4.01Changes in Registrant's Certifying Accountant. On August 12, 2010, Kraig Biocraft Laboratories, INC. (the "Company") terminated the engagement of Webb & Company, P.A. ("Webb & Co.") as the Company's independent registered public accounting firm. The termination was approved by the Company's Board of Directors. Concurrent with this action, the Company engaged, Board of Directors of the Company appointed, PS Stephenson & Company PC. ("PS Stephenson &a...
Read article

KraigBiocraft Laboratories Enters Into New Collaborative R&D Agreement With the University of Notre Dame

Keywords: KraigBiocraft Laboratories Enters Into New Collaborative R&D Agreement With the University of Notre Dame, kblb.ob
Quote:
Read article

Kraig Biocraft Laboratories, Inc. S1 Registration is Declared Effective

Keywords: Kraig Biocraft Laboratories, Inc. S1 Registration is Declared Effective, kblb.ob
Quote: We want to thank all of our shareholders for their patienceduring this arduous process and we look forward to what we now believewill be a very successful year for Kraig Biocraft Laboratories.”Kraig is working to develop and commercialize high performance polymersusing spider silk gene sequences. The company plans to tap into the $92billion market for high performance and technical fibers. In 2007 KraigBiocraft Laboratories signed an intellectual property and collaborativeresearch agreemen...
Read article

KRAIG BIOCRAFT LABORATORIES, INC Files SEC form 8-K, Non-Reliance on Previous Financials, Audits or Interim Review

Quote:
Read article

Kraig Biocraft Laboratories, Inc. Gears Up to Double the Number of Genetic Insertions Performed

Quote: In 2007 Kraig Biocraft Laboratories signed an intellectual property and collaborative research agreement with the University of Notre Dame. Since that time the Company has been a proud sponsor of scientific research and development within the university. www.KraigLabs.com This press release includes certain statements that may be deemed to be "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act o...
Read article

Kraig Biocraft Laboratories, Inc. Successfully Creates Genetic Constructs for Several Unique Fusion Silk Proteins

Quote: In 2007, Kraig Biocraft Laboratories signed an intellectual property and collaborative research agreement with the University of Notre Dame. Since that time, the Company has been a proud sponsor of scientific research and development within the university. www.KraigLabs.com. http://www.globenewswire.com/newsroom/prs/?pkgid=4817 This press release includes certain statements that may be deemed to be "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as ...
Read article

SectorWatch.biz: Paving the Way for Spider Silk

Quote: perhaps until now. Enter Kraig Biocraft Laboratories, which is developing a way of inserting spider silk DNA directly into silkworms allowing the silkworms to produce the proteins for spider silk. This genetically-engineered spider silk could conceivably dominate the high performance fiber market, a market potentially worth billions. http://www.usequitynews.com/news/the-new-silk.html SectorWatch.biz is powered by Market Pathways, a leader in the representation of smallcap equities for nearly t...
Read article

Kraig Biocraft Laboratories, Inc. Issues Stock Dividend

Quote: In 2007 Kraig Biocraft Laboratories signed an intellectual property and collaborative research agreement with the University of Notre Dame. Since that time the Company has been a proud sponsor of scientific research and development within the university. www.KraigLabs.com http://www.globenewswire.com/newsroom/prs/?pkgid=4817 This press release includes certain statements that may be deemed to be "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as ame...
Read article

SectorWatch.biz: The Super-Fiber Revolution

Quote: Spider silk can also stretch about 30% longer than its original length without breaking, making its threads extremely resilient. Kraig Biocraft Laboratories is developing a way of inserting spider silk DNA directly into silkworms allowing silkworms to produce the proteins for spider silk. Kraig is working in cooperation with University of Notre Dame scientists and laboratories to create new polymers with potentially broad applications for consumers and industry in the $92 billion marketplace fo...
Read article

Kraig Biocraft Laboratories, Inc. Gears Up to Double the Number of Genetic Insertions Performed

Quote: In 2007 Kraig Biocraft Laboratories signed an intellectual property and collaborative research agreement with the University of Notre Dame. Since that time the Company has been a proud sponsor of scientific research and development within the university. www.KraigLabs.com This press release includes certain statements that may be deemed to be "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act o...
Read article

Kraig Biocraft Laboratories, Inc. Successfully Creates Genetic Constructs for Several Unique Fusion Silk Proteins

Quote: In 2007, Kraig Biocraft Laboratories signed an intellectual property and collaborative research agreement with the University of Notre Dame. Since that time, the Company has been a proud sponsor of scientific research and development within the university. www.KraigLabs.com. http://www.globenewswire.com/newsroom/prs/?pkgid=4817 This press release includes certain statements that may be deemed to be "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as ...
Read article

SectorWatch.biz: Paving the Way for Spider Silk

Quote: perhaps until now. Enter Kraig Biocraft Laboratories, which is developing a way of inserting spider silk DNA directly into silkworms allowing the silkworms to produce the proteins for spider silk. This genetically-engineered spider silk could conceivably dominate the high performance fiber market, a market potentially worth billions. http://www.usequitynews.com/news/the-new-silk.html SectorWatch.biz is powered by Market Pathways, a leader in the representation of smallcap equities for nearly t...
Read article

Kraig Biocraft Laboratories, Inc. Issues Stock Dividend

Quote: In 2007 Kraig Biocraft Laboratories signed an intellectual property and collaborative research agreement with the University of Notre Dame. Since that time the Company has been a proud sponsor of scientific research and development within the university. www.KraigLabs.com http://www.globenewswire.com/newsroom/prs/?pkgid=4817 This press release includes certain statements that may be deemed to be "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as ame...
Read article

SectorWatch.biz: The Super-Fiber Revolution

Quote: Spider silk can also stretch about 30% longer than its original length without breaking, making its threads extremely resilient. Kraig Biocraft Laboratories is developing a way of inserting spider silk DNA directly into silkworms allowing silkworms to produce the proteins for spider silk. Kraig is working in cooperation with University of Notre Dame scientists and laboratories to create new polymers with potentially broad applications for consumers and industry in the $92 billion marketplace fo...
Read article

KRAIG BIOCRAFT LABORATORIES, INC Files SEC form 10-Q/A, Quarterly Report

Quote: Accordingly, in conjunction with reading this amendment to the Original Filing, you should also read all other filings we have made with the Securities and Exchange Commission since August 13, 2009. KRAIG BIOCRAFT LABORATORIES, INC. FORM 10-QJune 30, 2009INDEX PART I-- FINANCIAL INFORMATION Item 1.Financial Statements1 Item 2.Management's Discussion and Analysis of Financial Condition 17 Item 3Quantitative and Qualitative Disclosures About Market Risk19 Item 4T. Control and Procedures19 ...
Read article

KRAIG BIOCRAFT LABORATORIES, INC Files SEC form 8-K, Non-Reliance on Previous Financials, Audits or Interim Review

Quote: Item 4.02, Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review On November 20, 2009, Kim Thompson, President and Chief Executive Officer of Kraig Biocraft Laboratories, Inc.,(the "Company"), concluded that the previously issued financial statements for the period ended June 30, 2009 should no longer be relied upon because the Company did not account for a derivative liability associated with the CEO's employment agreement. Spe...
Read article

Would you like to leave a comment about Kraig Biocraft Laboratories, Inc. KBLB/KBLB.OB

Besides Kraig Biocraft Laboratories, Inc.'s Stock there is more great penny stock and market information at Realpennies